Risk of second malignancies in patients with early-stage classical Hodgkin’s lymphoma treated in a modern era

Study demonstrates that patients with early stage Hodgkin’s disease treated in a more modern era were associated with a slightly lower incidence of developing second malignancies, while achieving similar survival outcomes.